• Mirum Pharmaceuticals CEO Christopher Peetz exercised employee stock options for 30,000 shares at $2.94 on June 1, 2026.
• Peetz sold 30,000 shares the same day in multiple trades at weighted average prices ranging from $94.64 to $99.66.
• Directly held common stock ended at 194,309 shares following the transactions.
• He also reported 187,500 shares held indirectly through the Peetz Family Trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001614740-26-000010), on June 02, 2026, and is solely responsible for the information contained therein.